Kansas senior forward Lilly Meister joins this week’s episode of K-Nation. Meister is averaging 9.8 points and 7.3 rebounds ...

Eli Lilly’s next-generation obesity treatment may prove highly effective for patients who have high BMI or suffer from obesity-related complications. The company has a diversified portfolio across ...

Investing.com -- Abivax shares jumped after fresh media reports revived speculation that U.S. drugmaker Eli Lilly is exploring a takeover of the French biotech company. The stock was up 9% in Paris by ...

A blood test being developed by Roche and Eli Lilly that could help diagnose patients with Alzheimer’s disease more quickly has been awarded breakthrough status by the FDA, which could help it to ...

Eli Lilly's gene-silencing drug lepodisiran has been shown to reduce lipoprotein(a) levels by more than 90% for at least six months with a single injection in a phase 2 trial, reinforcing its ...

Novo Nordisk (NVO) shares rallied on Tuesday after the U.S. FDA approved its Wegovy pill for weight management, marking a major milestone for the beleaguered obesity drugmaker and putting shares of ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Co. (LLY), Shell plc ...

The Indiana FFA Foundation recently received a $750,000 grant from the Lilly Endowment to make significant improvements to the Indiana FFA Leadership Center in Trafalgar. The grant money came through ...

The first is the rollout of pills. Novo Nordisk is likely to be the first to market, as it was with its auto-injector pens, Ozempic for diabetes and Wegovy for obesity. Oral semaglutide, which has the ...

U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The U.S. Food and Drug Administration's ...